Position in IONS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,067,525
-$16,260,332 QoQ
Shares Held
114,359
-64.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 514 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. IONS ranks #40 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in IONS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,067,525 | 114,359 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $25,327,857 | 320,160 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $17,789,535 | 450,254 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,892,738 | 858,228 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $59,948,079 | 1,714,762 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $81,208,069 | 2,027,161 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $48,581,792 | 1,019,341 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,623,863 | 1,236,998 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $59,288,242 | 1,171,936 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $52,342,083 | 1,153,926 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $41,547,716 | 1,012,618 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $40,482,376 | 1,132,691 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $48,974,357 | 1,296,647 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $52,666,916 | 1,190,751 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $41,400,983 | 1,118,341 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $29,097,179 | 785,561 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $25,293,994 | 831,219 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $38,467,629 | 1,146,918 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $35,752,968 | 896,289 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $36,304,660 | 807,488 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $42,994,429 | 760,425 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $40,983,324 | 863,716 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $52,247,109 | 886,145 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $50,383,317 | 1,065,637 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||